Over 12 months, Entrada Therapeutics, Inc. saw more selling than buying from its insiders — purchases of about $1.6 million against sales of $15.1 million.
The largest purchase came from Baker Bros. Advisors (GP) LLC (10% Owner), about $625,000.
Quarter by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters. 129 investment managers listed TRDA in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | MPM BioVentures 2018 GP LLC | 10% Owner | Sell | 38,500 | $7.11 | $274K | SEC |
| Sep 9, 2026 | MPM BioVentures 2018 GP LLC | 10% Owner | Sell | 28,837 | $7.13 | $206K | SEC |
| Sep 9, 2026 | MPM BioVentures 2018 GP LLC | 10% Owner | Sell | 192,500 | $7.41 | $1.4M | SEC |
| Sep 9, 2026 | MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | Sell | 38,500 | $7.11 | $274K | SEC |
| Sep 9, 2026 | MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | Sell | 192,500 | $7.41 | $1.4M | SEC |
| Sep 9, 2026 | MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | Sell | 28,837 | $7.13 | $206K | SEC |
| Sep 3, 2026 | MPM BioVentures 2018 LLC | 10% Owner | Sell | 29,088 | $7.06 | $205K | SEC |
| Sep 3, 2026 | MPM BioVentures 2018 LLC | 10% Owner | Sell | 25,131 | $7.19 | $181K | SEC |
| Sep 3, 2026 | MPM BioVentures 2018 LLC | 10% Owner | Sell | 32,263 | $7.17 | $231K | SEC |
| Sep 3, 2026 | MPM BioVentures 2014 GP LLC | 10% Owner | Sell | 29,088 | $7.06 | $205K | SEC |
| Sep 3, 2026 | MPM BioVentures 2014 GP LLC | 10% Owner | Sell | 32,263 | $7.17 | $231K | SEC |
| Sep 3, 2026 | MPM BioVentures 2014 GP LLC | 10% Owner | Sell | 25,131 | $7.19 | $181K | SEC |
| Aug 31, 2026 | MPM BioVentures 2018 LLC | 10% Owner | Sell | 3,733 | $7.01 | $26K | SEC |
| Aug 31, 2026 | MPM BioVentures 2018 LLC | 10% Owner | Sell | 44,259 | $6.99 | $309K | SEC |
| Aug 31, 2026 | MPM BioVentures 2014 (B), L.P. | 10% Owner | Sell | 3,733 | $7.01 | $26K | SEC |
In the last 12 months Entrada Therapeutics, Inc. insiders made open-market purchases worth about $1.6 million and sales worth about $15.1 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in TRDA was filed on 2026-09-09.
129 investment managers reported holding TRDA in SEC Form 13F filings for Q2 2026.
No congressional trades in TRDA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).